Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series

Background: Influenza virus infection is an important cause of under-five mortality. Maternal vaccination protects children younger than 3 months of age from influenza infection. However, it is unknown to what extent paediatric influenza-related mortality may be prevented by a maternal vaccine since...

Full description

Bibliographic Details
Main Authors: Yvette N Löwensteyn, Harish Nair, Marta C Nunes, Ichelle van Roessel, Femke S Vernooij, Joukje Willemsen, Louis J Bont, Natalie I Mazur
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702100225X
id doaj-7dc6d7e839eb4fbebbb0f621ed7fa65d
record_format Article
spelling doaj-7dc6d7e839eb4fbebbb0f621ed7fa65d2021-07-29T04:23:24ZengElsevierEClinicalMedicine2589-53702021-07-0137100945Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case seriesYvette N Löwensteyn0Harish Nair1Marta C Nunes2Ichelle van Roessel3Femke S Vernooij4Joukje Willemsen5Louis J Bont6Natalie I Mazur7Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the NetherlandsRespiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, the Netherlands; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UKRespiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, the Netherlands; South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the NetherlandsDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the NetherlandsDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the NetherlandsDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands; Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, the NetherlandsDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands; Corresponding author.Background: Influenza virus infection is an important cause of under-five mortality. Maternal vaccination protects children younger than 3 months of age from influenza infection. However, it is unknown to what extent paediatric influenza-related mortality may be prevented by a maternal vaccine since global age-stratified mortality data are lacking. Methods: We invited clinicians and researchers to share clinical and demographic characteristics from children younger than 5 years who died with laboratory-confirmed influenza infection between January 1, 1995 and March 31, 2020. We evaluated the potential impact of maternal vaccination by estimating the number of children younger than 3 months with in-hospital influenza-related death using published global mortality estimates. Findings: We included 314 children from 31 countries. Comorbidities were present in 166 (53%) children and 41 (13%) children were born prematurely. Median age at death was 8·6 (IQR 4·5–16·6), 11·5 (IQR 4·3–24·0), and 15·5 (IQR 7·4–27·0) months for children from low- and lower-middle-income countries (LMICs), upper-middle-income countries (UMICs), and high-income countries (HICs), respectively. The proportion of children younger than 3 months at time of death was 17% in LMICs, 12% in UMICs, and 7% in HICs. We estimated that 3339 annual influenza-related in-hospital deaths occur in the first 3 months of life globally. Interpretation: In our study, less than 20% of children is younger than 3 months at time of influenza-related death. Although maternal influenza vaccination may impact maternal and infant influenza disease burden, additional immunisation strategies are needed to prevent global influenza-related childhood mortality. The missing data, global coverage, and data quality in this study should be taken into consideration for further interpretation of the results. Funding: Bill & Melinda Gates Foundation.http://www.sciencedirect.com/science/article/pii/S258953702100225X
collection DOAJ
language English
format Article
sources DOAJ
author Yvette N Löwensteyn
Harish Nair
Marta C Nunes
Ichelle van Roessel
Femke S Vernooij
Joukje Willemsen
Louis J Bont
Natalie I Mazur
spellingShingle Yvette N Löwensteyn
Harish Nair
Marta C Nunes
Ichelle van Roessel
Femke S Vernooij
Joukje Willemsen
Louis J Bont
Natalie I Mazur
Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
EClinicalMedicine
author_facet Yvette N Löwensteyn
Harish Nair
Marta C Nunes
Ichelle van Roessel
Femke S Vernooij
Joukje Willemsen
Louis J Bont
Natalie I Mazur
author_sort Yvette N Löwensteyn
title Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
title_short Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
title_full Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
title_fullStr Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
title_full_unstemmed Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
title_sort estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: a retrospective case series
publisher Elsevier
series EClinicalMedicine
issn 2589-5370
publishDate 2021-07-01
description Background: Influenza virus infection is an important cause of under-five mortality. Maternal vaccination protects children younger than 3 months of age from influenza infection. However, it is unknown to what extent paediatric influenza-related mortality may be prevented by a maternal vaccine since global age-stratified mortality data are lacking. Methods: We invited clinicians and researchers to share clinical and demographic characteristics from children younger than 5 years who died with laboratory-confirmed influenza infection between January 1, 1995 and March 31, 2020. We evaluated the potential impact of maternal vaccination by estimating the number of children younger than 3 months with in-hospital influenza-related death using published global mortality estimates. Findings: We included 314 children from 31 countries. Comorbidities were present in 166 (53%) children and 41 (13%) children were born prematurely. Median age at death was 8·6 (IQR 4·5–16·6), 11·5 (IQR 4·3–24·0), and 15·5 (IQR 7·4–27·0) months for children from low- and lower-middle-income countries (LMICs), upper-middle-income countries (UMICs), and high-income countries (HICs), respectively. The proportion of children younger than 3 months at time of death was 17% in LMICs, 12% in UMICs, and 7% in HICs. We estimated that 3339 annual influenza-related in-hospital deaths occur in the first 3 months of life globally. Interpretation: In our study, less than 20% of children is younger than 3 months at time of influenza-related death. Although maternal influenza vaccination may impact maternal and infant influenza disease burden, additional immunisation strategies are needed to prevent global influenza-related childhood mortality. The missing data, global coverage, and data quality in this study should be taken into consideration for further interpretation of the results. Funding: Bill & Melinda Gates Foundation.
url http://www.sciencedirect.com/science/article/pii/S258953702100225X
work_keys_str_mv AT yvettenlowensteyn estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries
AT harishnair estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries
AT martacnunes estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries
AT ichellevanroessel estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries
AT femkesvernooij estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries
AT joukjewillemsen estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries
AT louisjbont estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries
AT natalieimazur estimatedimpactofmaternalvaccinationonglobalpaediatricinfluenzarelatedinhospitalmortalityaretrospectivecaseseries
_version_ 1721259520914620416